<DOC>
	<DOCNO>NCT00670228</DOCNO>
	<brief_summary>Primary objective : To demonstrate hyperglycemic subject anterior STEMI ( ST Elevation Myocardial Infarction ) undergo Percutaneous Coronary Intervention ( PCI ) , tight glycemic control use insulin glulisine insulin glargine , i.e . Intensive Insulin Therapy ( IIT ) , result reduce infarct size day 60 versus ( v ) Standard Glycemic Care ( SGC ) . Secondary objective : To demonstrate tight glycemic control use insulin glulisine insulin glargine reduce marker inflammation improve Left Ventricular ( LV ) function Cardio-Vascular ( CV ) outcomes baseline value , hyperglycemic subject STEMI undergo Percutaneous Coronary Intervention ( PCI ) .</brief_summary>
	<brief_title>Effect Lantus Apidra Patients With Acute ST Elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Men woman = &gt; 35 year age present hospital hyperglycemia ( plasma glucose &gt; 140 mg/dL ) Primary Anterior wall STElevation Myocardial Infarction ( AW STEMI ) No history illicit drug abuse past year A minimum 30 minute &lt; = 6 hour continuous pain/symptoms immediately prior presentation Subjects undergo primary percutaneous coronary intervention ( PCI ) At least 2 contiguous precordial lead demonstrate least 2 mm STsegment elevation consistent anterior wall MI Signed informed consent HIPAA documentation ( US ) prior participation study Subjects ability willingness adhere compliant study protocol A prior history Myocardial Infarction ( MI ) Subjects receive thrombolytic therapy current hospital admission Severe Heart Failure cardiogenic shock ( Killip class 3 4 ) history present time screen Subjects plasma glucose &gt; 400 mg/dL diabetic ketoacidosis ( DKA ) History Type 1 diabetes Active bleed Active malignancy , chronic medical condition likely result death next one year Recent hypotension require inotropic support past 30 day Participation another clinical research study past 30 day Pregnant lactate woman ( woman childbearing potential must negative pregnancy test study entry medically approve contraception method ) Unwilling give inform consent Subjects directly involve conduct study Known hypersensitivity insulin glargine glulisine Contraindication MRI : ) Intracranial aneurysm clip ( Unless investigator certain make nonferromagnetic material titanium ) b ) Intraorbital metal fragment c ) Any electrically , magnetically mechanically activated implant ( include cardiac pacemaker , biostimulators , neurostimulators , cochlear implant , hear aid ) ) Warning Gadoliniumbased contrast agent ( GBCAs ) Exposure GBCAs increase risk nephrogenic systemic fibrosis ( NSF ) . Therefore follow subject exclude trial base history and/or laboratory test : acute chronic severe renal insufficiency ( glomerular filtration rate &lt; 30 mL/min/1.73m2 ) , calculate MDRD ( Modification diet Renal Disease ) equation , acute renal insufficiency severity Subjects blood pressure &gt; = 200/110 mmHg time randomization Subjects high degree nontransient AV ( AtrioVentricular ) block The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>